SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Mobia Medical, Inc. Common Stock
MOBI
Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.
Open XNAS
Fundamentals
Key company ratios and reported financial statements.
Key ratios
Valuation
- Market capitalization
- $437.78M
- Price / earnings
- —
- Price / book
- 2.77×
- Price / sales
- 10.63×
- EV / sales
- 6.9×
- EV / EBITDA
- -5.36×
Profitability
- Earnings per share
- -$1.69
- Return on assets
- -30.98%
- Return on equity
- -35.54%
- Dividend yield
- 0%
Liquidity and leverage
- Debt / equity
- 0.05×
- Current ratio
- 11.79×
- Quick ratio
- 11.24×
- Cash ratio
- 10.63×
Cash flow
- Price / cash flow
- —
- Price / free cash flow
- —
- Free cash flow
- -$59.79M
Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.
| Line item | Q3 FY2026 Sep 30, 2026 | Q2 FY2026 Jun 30, 2026 |
|---|---|---|
| Revenue | $15.62M | $13.51M |
| Cost of revenue | $2.62M | $2.27M |
| Gross profit | $13M | $11.24M |
| Selling, general and administrative | $28.98M | $26.89M |
| Research and development | $2.55M | $2.28M |
| Total operating expenses | $31.53M | $29.16M |
| Operating income | -$18.53M | -$17.93M |
| Interest expense | -$257K | -$254K |
| Income before taxes | -$17.34M | -$21.04M |
| Income taxes | $2K | $2K |
| Net income | -$17.35M | -$21.04M |
| Net income attributable to common shareholders | -$17.35M | -$21.04M |
| EBITDA | -$18.35M | -$17.79M |
| Basic earnings per share | -$0.52 | -$1.10 |
| Diluted earnings per share | -$0.52 | -$1.10 |
Recent news
Company coverage with links to the original publishers.
No recent company news found.
Dividends
Declared distributions and recorded event dates. Forecasts are not shown.
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.
| Execution date | Split ratio | Event type |
|---|---|---|
| Oct 20, 2009 | 1-for-600 | reverse split |